How Trump's psychedelics executive order could unlock stalled cannabis reform
CNBC Business·60-word summary·1 min read
The White House's recent psychedelics executive order, issued in 2026, aims to accelerate research and clinical trials for drugs like psilocybin, MDMA, and ibogaine, and expand "Right to Try" access. This move could potentially influence cannabis reform efforts, as it signals increased federal support for alternative therapies and drug policy shifts, impacting the broader macro-finance landscape.
The Roundhill Memory ETF (DRAM) launched on April 2nd has quickly amassed over $1 billion in assets, focusing on major memory stocks like SK Hynix, Micron, and Samsung. Its rapid growth highlights strong investor interest in memory chip exposure, with the ETF's concentration reflecting the sector's dominance in the market.
Bloomberg's Joel Weber challenged Scarlet Fu, Katie Greifeld, and Eric Balchunas on "Bloomberg ETF IQ," testing their knowledge of exchange-traded funds. The segment, part of this week's "IQ Test," aims to assess industry expertise. No specific amounts or dates were provided, but the event highlights ongoing interest in ETF market understanding among financial professionals.
The $21 trillion ETF industry is highlighted in Bloomberg ETF IQ, with Apollo Management Partner Andrew Gosden discussing its opportunities and risks. The segment, aired on April 20, 2026, features insights from Michael Baron of Baron Capital, emphasizing the sector's significant size and evolving trends within the global exchange-traded funds market.
Children’s Hospital Los Angeles plans to issue $187.5 million in federally taxable municipal revenue bonds to address financial pressures caused by Medicaid cuts from federal and state sources. The bond sale, announced in April 2026, aims to help the hospital manage the impact of reduced Medicaid funding, which has strained its budget amid ongoing healthcare funding challenges.
Disruptions in the Hormuz Strait are impacting China’s Christmas manufacturing hub, leading to increased costs for plastic and other materials. Manufacturers warn that these supply chain issues may result in higher prices for holiday goods, potentially affecting consumer spending during the festive season. The disruptions highlight ongoing macroeconomic challenges in global trade and supply chains.
Aevex Corp., a military drone manufacturer, saw its shares double within two trading days after its market debut. The rapid increase highlights strong investor interest in defense technology firms. The company’s quick stock surge reflects growing confidence in the sector, with Aevex’s debut marking a notable event in the defense and aerospace markets.
